Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Chemed Corporation's quarterly P/E stands at 19.5x, down 11.3% year-over-year — suggesting improving earnings relative to price.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 22.26 | 19.52 | 25.10 | 34.10 | 31.65 | 22.00 | 29.93 | 29.17 | 37.85 | 24.78 | 26.35 | 38.58 | 37.55 |
| — | -11.3% | -16.1% | +16.9% | -16.4% | -11.2% | +13.6% | -24.4% | +0.8% | -19.8% | -8.7% | +44.7% | +25.1% | |
| P/S Ratio | 2.29 | 2.34 | 2.60 | 2.87 | 3.51 | 3.10 | 3.74 | 3.47 | 4.18 | 3.81 | 3.50 | 3.72 | 3.63 |
| — | -24.5% | -30.4% | -17.2% | -16.0% | -18.6% | +6.9% | -6.7% | +15.2% | +8.4% | +12.2% | +11.5% | +0.0% | |
| P/B Ratio | 6.03 | 6.11 | 6.04 | 5.93 | 7.69 | 7.10 | 7.33 | 6.85 | 8.32 | 8.06 | 7.75 | 8.66 | 9.23 |
| — | -13.9% | -17.6% | -13.4% | -7.6% | -11.9% | -5.4% | -20.8% | -9.9% | -16.2% | -14.9% | -16.4% | -20.0% | |
| P/FCF | 17.77 | 12.77 | 24.64 | 14.48 | 116.68 | 13.05 | 29.44 | 31.13 | 34.01 | 23.06 | 114.34 | 17.78 | 46.73 |
| — | -2.1% | -16.3% | -53.5% | +243.1% | -43.4% | -74.3% | +75.1% | -27.2% | -1.6% | +168.6% | -56.3% | +114.8% | |
| EV / EBITDA | 17.31 | 15.04 | 17.91 | 20.77 | 20.44 | 15.24 | 20.80 | 19.74 | 27.45 | 17.37 | 19.23 | 24.29 | 23.49 |
| — | -1.3% | -13.9% | +5.2% | -25.6% | -12.3% | +8.2% | -18.7% | +16.9% | -15.1% | +8.0% | +41.8% | +23.0% | |
| EV / EBIT | 17.31 | — | 19.05 | 24.48 | 23.58 | 16.38 | 22.11 | 21.74 | 28.50 | 19.02 | 20.98 | 28.91 | 28.31 |
| — | — | -13.8% | +12.6% | -17.3% | -13.9% | +5.4% | -24.8% | +0.7% | -18.6% | -4.1% | +37.0% | +21.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Chemed Corporation's operating margin was 15.7% in Q4 2025, up 3.8 pp QoQ and down 2.1 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 13.3% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 28.9% | 29.8% | 33.5% | 36.6% | 34.6% | 34.6% | 34.6% | 38.8% | 35.8% | 32.4% | 33.8% |
| — | — | -16.5% | -13.7% | -3.4% | -5.8% | -3.3% | +6.7% | +2.4% | +7.7% | +5.0% | -11.4% | -7.5% | |
| Operating Margin | 13.4% | 15.7% | 12.0% | 11.0% | 14.6% | 17.8% | 15.2% | 14.8% | 12.3% | 19.0% | 15.4% | 12.6% | 13.0% |
| — | -11.5% | -21.3% | -25.6% | +19.3% | -6.4% | -1.2% | +17.8% | -5.6% | +27.8% | +0.2% | -27.5% | -22.8% | |
| Net Margin | 10.5% | 12.0% | 10.3% | 8.5% | 11.1% | 14.1% | 12.5% | 11.9% | 11.0% | 15.4% | 13.3% | 9.6% | 9.7% |
| — | -14.9% | -17.8% | -28.7% | +0.5% | -8.2% | -5.9% | +23.4% | +14.2% | +35.2% | +22.9% | -22.9% | -20.1% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.3% | 7.5% | 5.6% | 4.4% | 6.2% | 7.7% | 6.2% | 5.9% | 5.7% | 8.5% | 7.6% | 5.8% | 6.4% |
| — | -2.7% | -9.0% | -25.6% | +9.9% | -9.4% | -18.4% | +1.8% | -12.0% | +3.6% | -6.0% | -40.7% | -35.2% | |
| ROA | 16.5% | 4.9% | 3.8% | 3.0% | 4.2% | 5.3% | 4.3% | 4.1% | 3.8% | 5.6% | 4.9% | 3.6% | 3.8% |
| — | -7.6% | -11.1% | -25.6% | +10.4% | -5.8% | -11.5% | +12.6% | +1.6% | +25.6% | +14.7% | -28.4% | -22.3% | |
| ROIC | 23.8% | 7.1% | 5.1% | 4.5% | 6.4% | 7.7% | 6.1% | 6.2% | 5.4% | 8.4% | 6.8% | 5.4% | 5.6% |
| — | -7.9% | -15.4% | -26.2% | +18.2% | -9.0% | -10.7% | +13.4% | -3.4% | +33.5% | +6.2% | -27.1% | -23.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Chemed Corporation's Debt/EBITDA ratio is 1.4x, down from 1.6x last quarter — comfortably within a safe range. The current ratio has weakened 23.7% YoY to 1.05x, tightening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.13 | 0.12 | 0.12 | 0.13 | 0.12 | 0.12 | 0.12 | 0.14 | 0.13 | 0.15 | 0.19 |
| — | +16.6% | +9.8% | +0.2% | -0.6% | -10.1% | -10.9% | -18.1% | -34.4% | -54.7% | -60.6% | -60.9% | -53.1% | |
| Debt / EBITDA | 0.43 | 1.43 | 1.55 | 1.73 | 1.31 | 1.09 | 1.37 | 1.41 | 1.66 | 1.22 | 1.34 | 1.66 | 1.89 |
| — | +31.5% | +13.4% | +22.4% | -21.0% | -11.1% | +2.4% | -15.3% | -12.4% | -52.5% | -48.0% | -31.2% | -26.6% | |
| Current Ratio | 1.05 | 1.05 | 1.35 | 1.86 | 1.73 | 1.38 | 1.85 | 1.78 | 1.91 | 1.61 | 1.33 | 1.11 | 0.93 |
| — | -23.7% | -26.9% | +4.9% | -9.6% | -13.9% | +39.5% | +59.2% | +106.9% | +75.0% | +99.0% | +56.4% | +40.0% | |
| Quick Ratio | 1.03 | 1.03 | 1.33 | 1.83 | 1.70 | 1.35 | 1.81 | 1.73 | 1.88 | 1.57 | 1.29 | 1.08 | 0.89 |
| — | -24.0% | -27.0% | +5.4% | -9.2% | -13.6% | +41.2% | +61.2% | +111.4% | +77.5% | +103.4% | +59.4% | +42.5% | |
| Interest Coverage | — | — | 37.36 | 153.69 | 288.02 | 228.21 | 215.82 | 205.42 | 170.20 | 325.71 | 195.61 | 90.15 | 46.95 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonChemed Corporation's current P/E is 22.3x. The average P/E over the last 4 quarters is 27.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Chemed Corporation's current operating margin is 13.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Chemed Corporation's business trajectory between earnings reports.